South Africa Must Revoke Key COVID-19 Patents, Says MSF

Eli Lilly’s Olumiant (baricitinib) patent in South Africa is unjustifiably preventing generics manufacturers from selling cheaper versions of the drug in the country, MSF insists. The arthritis drug has been recommended as a treatment for severe and critical cases of COVID-19 by the WHO.